Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter
- PMID: 33992806
- PMCID: PMC8822133
- DOI: 10.1016/j.ymthe.2021.05.013
Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter
Abstract
Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the catecholamine (CA) biosynthesis pathway, making TH a molecular target for controlling CA production, specifically dopamine. Dysregulation of dopamine is correlated with neurological diseases such as Parkinson's disease (PD) and post-traumatic stress disorder (PTSD), among others. Previously, we showed that a 49-nucleotide guanine (G)-rich sequence within the human TH promoter adopts two different sets of G-quadruplex (GQ) structures (5'GQ and 3'GQ), where the 5'GQ uses G-stretches I, II, IV, and VI in TH49, which enhances TH transcription, while the 3'GQ utilizes G-stretches II, IV, VI, and VII, which represses transcription. Herein, we demonstrated targeted switching of these GQs to their active state using rationally designed DNA GQ Clips (5'GQ and 3'GQ Clips) to modulate endogenous TH gene expression and dopamine production. As a translational approach, we synthesized a targeted nanoparticle delivery system to effectively deliver the 5'GQ Clip in vivo. We believe this strategy could potentially be an improved approach for controlling dopamine production in a multitude of neurological disorders, including PD.
Keywords: G-quadruplex; Parkinson’s disease; dopamine; nanoparticles; nucleic acids therapeutics; targeted drug delivery; tyrosine hydroxylase.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures







Similar articles
-
G-Quadruplex-Enabling Sequence within the Human Tyrosine Hydroxylase Promoter Differentially Regulates Transcription.Biochemistry. 2015 Sep 15;54(36):5533-45. doi: 10.1021/acs.biochem.5b00209. Epub 2015 Aug 28. Biochemistry. 2015. PMID: 26284527
-
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.J Neural Transm (Vienna). 2016 Nov;123(11):1255-1278. doi: 10.1007/s00702-016-1596-4. Epub 2016 Aug 4. J Neural Transm (Vienna). 2016. PMID: 27491309 Review.
-
Overview of tyrosine hydroxylase in Parkinson's disease.CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):350-8. doi: 10.2174/187152712800792901. CNS Neurol Disord Drug Targets. 2012. PMID: 22483316 Review.
-
Current status of tyrosine hydroxylase in management of Parkinson's disease.CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):450-5. doi: 10.2174/187152712800792910. CNS Neurol Disord Drug Targets. 2012. PMID: 22583428 Review.
-
Human tyrosine hydroxylase in Parkinson's disease and in related disorders.J Neural Transm (Vienna). 2019 Apr;126(4):397-409. doi: 10.1007/s00702-018-1903-3. Epub 2018 Jul 11. J Neural Transm (Vienna). 2019. PMID: 29995172 Review.
Cited by
-
Recognition Interface of the Thrombin Binding Aptamer Requires Antiparallel Topology of the Quadruplex Core.Biomolecules. 2021 Sep 9;11(9):1332. doi: 10.3390/biom11091332. Biomolecules. 2021. PMID: 34572544 Free PMC article.
-
Stalling of Transcription by Putative G-quadruplex Sequences and CRISPR-dCas9.bioRxiv [Preprint]. 2024 Mar 17:2024.03.17.585391. doi: 10.1101/2024.03.17.585391. bioRxiv. 2024. PMID: 38559215 Free PMC article. Preprint.
References
-
- Molinoff P.B., Axelrod J. Biochemistry of catecholamines. Annu. Rev. Biochem. 1971;40:465–500. - PubMed
-
- Tripp G., Wickens J.R. Neurobiology of ADHD. Neuropharmacology. 2009;57:579–589. - PubMed
-
- Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J. Psychopharmacol. 1997;11:151–162. - PubMed
-
- Assadi S.M., Yücel M., Pantelis C. Dopamine modulates neural networks involved in effort-based decision-making. Neurosci. Biobehav. Rev. 2009;33:383–393. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials